关注
Dominic Raj
Dominic Raj
在 mfa.gwu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
A Parsa, WHL Kao, D Xie, BC Astor, M Li, C Hsu, HI Feldman, RS Parekh, ...
New England Journal of Medicine 369 (23), 2183-2196, 2013
7702013
The gut microbiome, kidney disease, and targeted interventions
A Ramezani, DS Raj
Journal of the American Society of Nephrology 25 (4), 657-670, 2014
7652014
Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC
J Gupta, N Mitra, PA Kanetsky, J Devaney, MR Wing, M Reilly, VO Shah, ...
Clinical journal of the American Society of Nephrology 7 (12), 1938-1946, 2012
6122012
Fibroblast growth factor-23 and cardiovascular events in CKD
JJ Scialla, H Xie, M Rahman, AH Anderson, T Isakova, A Ojo, X Zhang, ...
Journal of the American Society of Nephrology 25 (2), 349-360, 2014
5442014
Nocturnal hemodialysis: three-year experience.
A Pierratos, M Ouwendyk, R Francoeur, S Vas, DS Raj, AM Ecclestone, ...
Journal of the American Society of Nephrology 9 (5), 859-868, 1998
5061998
Trimethylamine N-Oxide: The Good, the Bad and the Unknown
MT Velasquez, A Ramezani, A Manal, DS Raj
Toxins 8 (11), 326, 2016
4502016
Advanced glycation end products: a Nephrologist's perspective
DSC Raj, D Choudhury, TC Welbourne, M Levi
American journal of kidney diseases 35 (3), 365-380, 2000
4412000
Inflammation and progression of CKD: the CRIC study
RL Amdur, HI Feldman, J Gupta, W Yang, P Kanetsky, M Shlipak, ...
Clinical journal of the American Society of Nephrology 11 (9), 1546-1556, 2016
4132016
Role of the gut microbiome in uremia: a potential therapeutic target
A Ramezani, ZA Massy, B Meijers, P Evenepoel, R Vanholder, DS Raj
American Journal of Kidney Diseases 67 (3), 483-498, 2016
3692016
Wasting in chronic kidney disease
RH Mak, AT Ikizler, CP Kovesdy, DS Raj, P Stenvinkel, K Kalantar-Zadeh
Journal of cachexia, sarcopenia and muscle 2 (1), 9-25, 2011
3472011
Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease
J Chen, MJ Budoff, MP Reilly, W Yang, SE Rosas, M Rahman, X Zhang, ...
JAMA cardiology 2 (6), 635-643, 2017
3392017
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
PM Ridker, M Devalaraja, FMM Baeres, MDM Engelmann, GK Hovingh, ...
The Lancet 397 (10289), 2060-2069, 2021
3372021
Fibroblast growth factor 23 and Inflammation in CKD
JM Mendoza, T Isakova, AC Ricardo, H Xie, SD Navaneethan, ...
Clinical Journal of the American Society of Nephrology 7 (7), 1155-1162, 2012
3162012
Diets and enteral supplements for improving outcomes in chronic kidney disease
K Kalantar-Zadeh, NJ Cano, K Budde, C Chazot, CP Kovesdy, RH Mak, ...
Nature Reviews Nephrology 7 (7), 369-384, 2011
2752011
Gut microbiome in chronic kidney disease: challenges and opportunities
A Nallu, S Sharma, A Ramezani, J Muralidharan, D Raj
Translational Research 179, 24-37, 2017
2562017
Role of interleukin-6 in the anemia of chronic disease
DSC Raj
Seminars in arthritis and rheumatism 38 (5), 382-388, 2009
2532009
Gut microbiota in hypertension
PA Jose, D Raj
Current opinion in nephrology and hypertension 24 (5), 403-409, 2015
2112015
β 2-Microglobulin kinetics in nocturnal haemodialysis
DSC Raj, M Ouwendyk, R Francoeur, A Pierratos
Nephrology Dialysis Transplantation 15 (1), 58-64, 2000
1972000
Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin
DSC Raj, B Vincent, K Simpson, E Sato, KL Jones, TC Welbourne, M Levi, ...
Kidney international 61 (2), 697-704, 2002
1892002
Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study
M Rahman, W Yang, S Akkina, A Alper, AH Anderson, LJ Appel, J He, ...
Clinical journal of the American Society of Nephrology 9 (7), 1190-1198, 2014
1662014
系统目前无法执行此操作,请稍后再试。
文章 1–20